Delivery Order SPE2DB20D6035-SPE2DB25FLYEX
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count quantity. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $28,009.13 and is scheduled for completion by September 10, 2025. The contract represents a single line item fulfillment under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA, with performance to occur...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,537.32 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count bottles) on October 28, 2025, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Losartan-HCTZ is a combination antihypertensive...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) valued at $4,309.59 on November 5, 2025, with completion expected by November 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,560.68 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count units) on October 31, 2025, with an ultimate completion date of November 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,143.92 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count bottles) under a firm fixed price contract. This non-competitive delivery order, issued on November 3, 2025, with completion expected by November 4, 2025, represents a small-value pharmaceutical procurement fulfilling federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,436.44 firm fixed-price delivery order contract (SPE2DX15D3015|SPE2DX24F0EN0) to AmerisourceBergen Drug Corp for the supply of 4,563,434,205 units of Losartan-HCTZ 50-12.5 mg tablets. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) with a ceiling value of $2,277.71. This is a firm fixed-price delivery order with no set-aside designation, competed openly, and is scheduled for completion by June 25, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a ceiling value of $1,867.39. This firm fixed-price delivery order has an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded among...
- The Defense Logistics Agency awarded a $5,910.20 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. This firm fixed-price delivery order, which is not set-aside designated, is set to complete on July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,820.43 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on November 4, 2025, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...